ID   CD22_HUMAN              Reviewed;         847 AA.
AC   P20273; F5GYU4; F5H7U3; O95699; O95701; O95702; O95703; Q01665; Q32M46;
AC   Q92872; Q92873; Q9UQA6; Q9UQA7; Q9UQA8; Q9UQA9; Q9UQB0; Q9Y2A6;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   03-AUG-2022, entry version 226.
DE   RecName: Full=B-cell receptor CD22 {ECO:0000305};
DE   AltName: Full=B-lymphocyte cell adhesion molecule;
DE            Short=BL-CAM;
DE   AltName: Full=Sialic acid-binding Ig-like lectin 2;
DE            Short=Siglec-2;
DE   AltName: Full=T-cell surface antigen Leu-14;
DE   AltName: CD_antigen=CD22;
DE   Flags: Precursor;
GN   Name=CD22 {ECO:0000303|PubMed:1691828, ECO:0000312|HGNC:HGNC:1643};
GN   Synonyms=SIGLEC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CD22-BETA).
RX   PubMed=1691828; DOI=10.1038/345074a0;
RA   Stamenkovic I., Seed B.;
RT   "The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion.";
RL   Nature 345:74-77(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM CD22-BETA), AND VARIANT HIS-639.
RC   TISSUE=Tonsil;
RX   PubMed=1985119; DOI=10.1084/jem.173.1.137;
RA   Wilson G.L., Fox C.H., Fauci A.S., Kehrl J.H.;
RT   "cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell
RT   interactions.";
RL   J. Exp. Med. 173:137-146(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS CD22-ALPHA AND CD22-BETA).
RX   PubMed=8496602;
RA   Wilson G.L., Najfeld V., Kozlow E., Menniger J., Ward D., Kehrl J.H.;
RT   "Genomic structure and chromosomal mapping of the human CD22 gene.";
RL   J. Immunol. 150:5013-5024(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Spleen;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 13-137; 139-239; 241-328 AND 418-502,
RP   AND VARIANTS THR-34; GLU-152; LYS-203; GLY-664; CYS-669 AND ASP-745.
RX   PubMed=10079291; DOI=10.1007/s002510050494;
RA   Hatta Y., Tsuchiya N., Matsushita M., Shiota M., Hagiwara K., Tokunaga K.;
RT   "Identification of the gene variations in human CD22.";
RL   Immunogenetics 49:280-286(1999).
RN   [8]
RP   SIALIC ACID-BINDING.
RX   PubMed=8463235; DOI=10.1016/s0021-9258(18)53140-9;
RA   Powell L.D., Sgroi D., Sjoberg E.R., Stamenkovic I., Varki A.;
RT   "Natural ligands of the B cell adhesion molecule CD22 beta carry N-linked
RT   oligosaccharides with alpha-2,6-linked sialic acids that are required for
RT   recognition.";
RL   J. Biol. Chem. 268:7019-7027(1993).
RN   [9]
RP   INTERACTION WITH PTPN6.
RX   PubMed=7618087; DOI=10.1126/science.7618087;
RA   Doody G.M., Justement L.B., Delibrias C.C., Matthews R.J., Lin J.,
RA   Thomas M.L., Fearon D.T.;
RT   "A role in B cell activation for CD22 and the protein tyrosine phosphatase
RT   SHP.";
RL   Science 269:242-244(1995).
RN   [10]
RP   INTERACTION WITH LYN; SYK AND PIK3R1/PIK3R2.
RX   PubMed=8647200; DOI=10.1002/eji.1830260610;
RA   Tuscano J.M., Engel P., Tedder T.F., Agarwal A., Kehrl J.H.;
RT   "Involvement of p72syk kinase, p53/56lyn kinase and phosphatidyl inositol-3
RT   kinase in signal transduction via the human B lymphocyte antigen CD22.";
RL   Eur. J. Immunol. 26:1246-1252(1996).
RN   [11]
RP   INTERACTION WITH PTPN6; SYK AND PLCG1.
RX   PubMed=8627166; DOI=10.1084/jem.183.2.547;
RA   Law C.L., Sidorenko S.P., Chandran K.A., Zhao Z., Shen S.H., Fischer E.H.,
RA   Clark E.A.;
RT   "CD22 associates with protein tyrosine phosphatase 1C, Syk, and
RT   phospholipase C-gamma(1) upon B cell activation.";
RL   J. Exp. Med. 183:547-560(1996).
RN   [12]
RP   REVIEW.
RX   PubMed=9143697; DOI=10.1146/annurev.immunol.15.1.481;
RA   Tedder T.F., Tuscano J., Sato S., Kehrl J.H.;
RT   "CD22, a B lymphocyte-specific adhesion molecule that regulates antigen
RT   receptor signaling.";
RL   Annu. Rev. Immunol. 15:481-504(1997).
CC   -!- FUNCTION: Mediates B-cell B-cell interactions. May be involved in the
CC       localization of B-cells in lymphoid tissues. Binds sialylated
CC       glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6-
CC       linked sialic acid. The sialic acid recognition site can be masked by
CC       cis interactions with sialic acids on the same cell surface. Upon
CC       ligand induced tyrosine phosphorylation in the immune response seems to
CC       be involved in regulation of B-cell antigen receptor signaling. Plays a
CC       role in positive regulation through interaction with Src family
CC       tyrosine kinases and may also act as an inhibitory receptor by
CC       recruiting cytoplasmic phosphatases via their SH2 domains that block
CC       signal transduction through dephosphorylation of signaling molecules.
CC   -!- SUBUNIT: Predominantly monomer of isoform CD22-beta. Also found as
CC       heterodimer of isoform CD22-beta and a shorter isoform. Interacts with
CC       PTPN6/SHP-1, LYN, SYK, PIK3R1/PIK3R2 and PLCG1 upon phosphorylation.
CC       Interacts with GRB2, INPP5D and SHC1 upon phosphorylation (By
CC       similarity). May form a complex with INPP5D/SHIP, GRB2 and SHC1.
CC       {ECO:0000250, ECO:0000269|PubMed:7618087, ECO:0000269|PubMed:8627166,
CC       ECO:0000269|PubMed:8647200}.
CC   -!- INTERACTION:
CC       P20273; P07948: LYN; NbExp=2; IntAct=EBI-78277, EBI-79452;
CC       P20273; P19174: PLCG1; NbExp=2; IntAct=EBI-78277, EBI-79387;
CC       P20273; P29350: PTPN6; NbExp=4; IntAct=EBI-78277, EBI-78260;
CC       P20273; P43405: SYK; NbExp=4; IntAct=EBI-78277, EBI-78302;
CC       P20273-5; Q86W74-2: ANKRD46; NbExp=3; IntAct=EBI-13320645, EBI-12109402;
CC       P20273-5; Q96HA8: NTAQ1; NbExp=3; IntAct=EBI-13320645, EBI-741158;
CC       P20273-5; Q9NV12: TMEM140; NbExp=3; IntAct=EBI-13320645, EBI-2844246;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=CD22-beta;
CC         IsoId=P20273-1; Sequence=Displayed;
CC       Name=CD22-alpha;
CC         IsoId=P20273-2; Sequence=VSP_002531;
CC       Name=3;
CC         IsoId=P20273-3; Sequence=VSP_045363;
CC       Name=4;
CC         IsoId=P20273-4; Sequence=VSP_047223, VSP_047224;
CC       Name=5;
CC         IsoId=P20273-5; Sequence=VSP_054619, VSP_054620;
CC   -!- TISSUE SPECIFICITY: B-lymphocytes.
CC   -!- DOMAIN: Contains 4 copies of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC   -!- PTM: Phosphorylation of Tyr-762, Tyr-807 and Tyr-822 are involved in
CC       binding to SYK, GRB2 and SYK, respectively. Phosphorylation of Tyr-842
CC       is involved in binding to SYK, PLCG2 and PIK3R1/PIK3R2.
CC   -!- PTM: Phosphorylated on tyrosine residues by LYN. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. SIGLEC (sialic
CC       acid binding Ig-like lectin) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA36988.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Siglec-2 [3 Fc Domains];
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Itlect_00001";
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - Glycan Binding;
CC       Note=Siglec-2;
CC       URL="http://www.functionalglycomics.org/glycomics/GBPServlet?&operationType=view&cbpId=cbp_hum_Itlect_269";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U62631; AAB06448.1; -; Genomic_DNA.
DR   EMBL; U62631; AAB06449.1; -; Genomic_DNA.
DR   EMBL; X59350; CAA42006.1; -; mRNA.
DR   EMBL; X52785; CAA36988.1; ALT_FRAME; mRNA.
DR   EMBL; AK225625; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC002132; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC109306; AAI09307.1; -; mRNA.
DR   EMBL; AB012995; BAA36564.1; -; Genomic_DNA.
DR   EMBL; AB012996; BAA36565.1; -; Genomic_DNA.
DR   EMBL; AB012997; BAA36566.1; -; Genomic_DNA.
DR   EMBL; AB012998; BAA36567.1; -; Genomic_DNA.
DR   EMBL; AB012999; BAA36568.1; -; Genomic_DNA.
DR   EMBL; AB013000; BAA36569.1; -; Genomic_DNA.
DR   EMBL; AB013002; BAA36571.1; -; Genomic_DNA.
DR   EMBL; AB013003; BAA36572.1; -; Genomic_DNA.
DR   EMBL; AB013004; BAA36573.1; -; Genomic_DNA.
DR   EMBL; AB013006; BAA36575.1; -; Genomic_DNA.
DR   CCDS; CCDS12457.1; -. [P20273-1]
DR   CCDS; CCDS54247.1; -. [P20273-4]
DR   CCDS; CCDS54248.1; -. [P20273-3]
DR   CCDS; CCDS54249.1; -. [P20273-2]
DR   CCDS; CCDS62634.1; -. [P20273-5]
DR   PIR; A35648; A35648.
DR   RefSeq; NP_001172028.1; NM_001185099.1. [P20273-3]
DR   RefSeq; NP_001172029.1; NM_001185100.1. [P20273-4]
DR   RefSeq; NP_001172030.1; NM_001185101.1. [P20273-2]
DR   RefSeq; NP_001265346.1; NM_001278417.1. [P20273-5]
DR   RefSeq; NP_001762.2; NM_001771.3. [P20273-1]
DR   PDB; 5VKJ; X-ray; 2.12 A; A=20-330.
DR   PDB; 5VKM; X-ray; 2.20 A; A=20-330.
DR   PDB; 5VL3; X-ray; 3.10 A; Q/R/S/T=22-330.
DR   PDB; 7O52; X-ray; 2.41 A; U=504-687.
DR   PDBsum; 5VKJ; -.
DR   PDBsum; 5VKM; -.
DR   PDBsum; 5VL3; -.
DR   PDBsum; 7O52; -.
DR   AlphaFoldDB; P20273; -.
DR   SASBDB; P20273; -.
DR   SMR; P20273; -.
DR   BioGRID; 107371; 37.
DR   ELM; P20273; -.
DR   IntAct; P20273; 14.
DR   MINT; P20273; -.
DR   STRING; 9606.ENSP00000085219; -.
DR   BindingDB; P20273; -.
DR   ChEMBL; CHEMBL3218; -.
DR   DrugBank; DB04958; Epratuzumab.
DR   DrugBank; DB05889; Inotuzumab ozogamicin.
DR   DrugBank; DB12688; Moxetumomab pasudotox.
DR   DrugCentral; P20273; -.
DR   GuidetoPHARMACOLOGY; 2786; -.
DR   UniLectin; P20273; -.
DR   GlyGen; P20273; 18 sites.
DR   iPTMnet; P20273; -.
DR   PhosphoSitePlus; P20273; -.
DR   BioMuta; CD22; -.
DR   DMDM; 6166019; -.
DR   jPOST; P20273; -.
DR   MassIVE; P20273; -.
DR   MaxQB; P20273; -.
DR   PaxDb; P20273; -.
DR   PeptideAtlas; P20273; -.
DR   PRIDE; P20273; -.
DR   ProteomicsDB; 24846; -.
DR   ProteomicsDB; 27594; -.
DR   ProteomicsDB; 53740; -. [P20273-1]
DR   ProteomicsDB; 53741; -. [P20273-2]
DR   ABCD; P20273; 34 sequenced antibodies.
DR   Antibodypedia; 3714; 2402 antibodies from 56 providers.
DR   DNASU; 933; -.
DR   Ensembl; ENST00000085219.10; ENSP00000085219.4; ENSG00000012124.17. [P20273-1]
DR   Ensembl; ENST00000341773.10; ENSP00000339349.6; ENSG00000012124.17. [P20273-2]
DR   Ensembl; ENST00000419549.6; ENSP00000403822.2; ENSG00000012124.17. [P20273-5]
DR   Ensembl; ENST00000536635.6; ENSP00000442279.1; ENSG00000012124.17. [P20273-3]
DR   Ensembl; ENST00000544992.6; ENSP00000441237.1; ENSG00000012124.17. [P20273-4]
DR   Ensembl; ENST00000594250.5; ENSP00000469984.1; ENSG00000012124.17. [P20273-2]
DR   GeneID; 933; -.
DR   KEGG; hsa:933; -.
DR   MANE-Select; ENST00000085219.10; ENSP00000085219.4; NM_001771.4; NP_001762.2.
DR   UCSC; uc002nzb.6; human. [P20273-1]
DR   CTD; 933; -.
DR   DisGeNET; 933; -.
DR   GeneCards; CD22; -.
DR   HGNC; HGNC:1643; CD22.
DR   HPA; ENSG00000012124; Tissue enhanced (brain, lymphoid tissue, ovary).
DR   MIM; 107266; gene.
DR   neXtProt; NX_P20273; -.
DR   OpenTargets; ENSG00000012124; -.
DR   PharmGKB; PA26201; -.
DR   VEuPathDB; HostDB:ENSG00000012124; -.
DR   eggNOG; KOG4475; Eukaryota.
DR   GeneTree; ENSGT01050000244990; -.
DR   HOGENOM; CLU_017949_0_0_1; -.
DR   InParanoid; P20273; -.
DR   OMA; GCYICNA; -.
DR   PhylomeDB; P20273; -.
DR   TreeFam; TF334827; -.
DR   PathwayCommons; P20273; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-5690714; CD22 mediated BCR regulation.
DR   Reactome; R-HSA-983695; Antigen activates B Cell Receptor (BCR) leading to generation of second messengers.
DR   SignaLink; P20273; -.
DR   BioGRID-ORCS; 933; 18 hits in 1080 CRISPR screens.
DR   ChiTaRS; CD22; human.
DR   GeneWiki; CD22; -.
DR   GenomeRNAi; 933; -.
DR   Pharos; P20273; Tclin.
DR   PRO; PR:P20273; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P20273; protein.
DR   Bgee; ENSG00000012124; Expressed in spleen and 160 other tissues.
DR   ExpressionAtlas; P20273; baseline and differential.
DR   Genevisible; P20273; HS.
DR   GO; GO:0009986; C:cell surface; ISS:ARUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; TAS:ARUK-UCL.
DR   GO; GO:0005769; C:early endosome; IDA:ARUK-UCL.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:ARUK-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0032809; C:neuronal cell body membrane; ISS:ARUK-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:ARUK-UCL.
DR   GO; GO:0055037; C:recycling endosome; IDA:ARUK-UCL.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0042609; F:CD4 receptor binding; ISS:ARUK-UCL.
DR   GO; GO:0001791; F:IgM binding; TAS:ARUK-UCL.
DR   GO; GO:0019903; F:protein phosphatase binding; ISS:ARUK-UCL.
DR   GO; GO:0033691; F:sialic acid binding; ISS:ARUK-UCL.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ARUK-UCL.
DR   GO; GO:0042113; P:B cell activation; IDA:ARUK-UCL.
DR   GO; GO:0007155; P:cell adhesion; NAS:ProtInc.
DR   GO; GO:0050859; P:negative regulation of B cell receptor signaling pathway; IDA:ARUK-UCL.
DR   GO; GO:0050849; P:negative regulation of calcium-mediated signaling; ISS:ARUK-UCL.
DR   GO; GO:0002638; P:negative regulation of immunoglobulin production; ISS:ARUK-UCL.
DR   GO; GO:0030888; P:regulation of B cell proliferation; ISS:ARUK-UCL.
DR   GO; GO:0030100; P:regulation of endocytosis; IDA:ARUK-UCL.
DR   GO; GO:0050776; P:regulation of immune response; ISS:ARUK-UCL.
DR   Gene3D; 2.60.40.10; -; 7.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF13895; Ig_2; 1.
DR   SMART; SM00409; IG; 7.
DR   SMART; SM00408; IGc2; 4.
DR   SUPFAM; SSF48726; SSF48726; 7.
DR   PROSITE; PS50835; IG_LIKE; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Disulfide bond; Glycoprotein; Immunoglobulin domain; Isopeptide bond;
KW   Lectin; Membrane; Phosphoprotein; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..847
FT                   /note="B-cell receptor CD22"
FT                   /id="PRO_0000014873"
FT   TOPO_DOM        20..687
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        688..706
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        707..847
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          20..138
FT                   /note="Ig-like V-type"
FT   DOMAIN          143..235
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          242..326
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          331..416
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          419..500
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          505..582
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          593..676
FT                   /note="Ig-like C2-type 6"
FT   MOTIF           760..765
FT                   /note="ITIM motif 1"
FT   MOTIF           794..799
FT                   /note="ITIM motif 2"
FT   MOTIF           820..825
FT                   /note="ITIM motif 3"
FT   MOTIF           840..845
FT                   /note="ITIM motif 4"
FT   BINDING         120
FT                   /ligand="N-acetylneuraminate"
FT                   /ligand_id="ChEBI:CHEBI:35418"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         725
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35329"
FT   MOD_RES         726
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35329"
FT   MOD_RES         729
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35329"
FT   MOD_RES         762
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35329"
FT   MOD_RES         807
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35329"
FT   MOD_RES         822
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35329"
FT   MOD_RES         842
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35329"
FT   CARBOHYD        67
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        112
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        135
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        164
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        231
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        363
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        445
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        479
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        574
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        634
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        39..167
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        44..102
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        161..219
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        265..309
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        353..396
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        442..484
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        529..571
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        616..659
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..3
FT                   /note="MHL -> MSL (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054619"
FT   VAR_SEQ         4..175
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054620"
FT   VAR_SEQ         241..417
FT                   /note="Missing (in isoform CD22-alpha)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_002531"
FT   VAR_SEQ         330..417
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_045363"
FT   VAR_SEQ         737..751
FT                   /note="VRRAPLSEGPHSLGC -> RCRVLRDAETSPGLR (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047223"
FT   VAR_SEQ         752..847
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047224"
FT   VARIANT         34
FT                   /note="A -> T (in dbSNP:rs201453271)"
FT                   /evidence="ECO:0000269|PubMed:10079291"
FT                   /id="VAR_014133"
FT   VARIANT         152
FT                   /note="Q -> E (observed with a marginally higher frequency
FT                   in patients with systemic lupus erythematosus;
FT                   dbSNP:rs554866571)"
FT                   /evidence="ECO:0000269|PubMed:10079291"
FT                   /id="VAR_003913"
FT   VARIANT         203
FT                   /note="E -> K (in dbSNP:rs752024645)"
FT                   /evidence="ECO:0000269|PubMed:10079291"
FT                   /id="VAR_014134"
FT   VARIANT         551
FT                   /note="G -> R (in dbSNP:rs35715143)"
FT                   /id="VAR_049903"
FT   VARIANT         639
FT                   /note="Y -> H (in dbSNP:rs1058407)"
FT                   /evidence="ECO:0000269|PubMed:1985119"
FT                   /id="VAR_014135"
FT   VARIANT         664
FT                   /note="S -> G (in dbSNP:rs17719289)"
FT                   /evidence="ECO:0000269|PubMed:10079291"
FT                   /id="VAR_003914"
FT   VARIANT         669
FT                   /note="R -> C (in dbSNP:rs749980313)"
FT                   /evidence="ECO:0000269|PubMed:10079291"
FT                   /id="VAR_003915"
FT   VARIANT         745
FT                   /note="G -> D (in dbSNP:rs10406069)"
FT                   /evidence="ECO:0000269|PubMed:10079291"
FT                   /id="VAR_003916"
FT   CONFLICT        486
FT                   /note="A -> R (in Ref. 1; CAA42006)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        788..789
FT                   /note="PD -> RT (in Ref. 1; CAA42006)"
FT                   /evidence="ECO:0000305"
FT   HELIX           21..23
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          24..28
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          30..35
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          40..42
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          45..48
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          54..65
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   TURN            66..69
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          70..78
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   TURN            79..81
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   HELIX           82..84
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   HELIX           87..89
FT                   /evidence="ECO:0007829|PDB:5VL3"
FT   STRAND          91..94
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          104..108
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   HELIX           111..113
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          115..122
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          127..139
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          144..146
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          157..164
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          172..178
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          187..196
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          198..206
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   HELIX           210..212
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          216..225
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          228..235
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          239..250
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          251..253
FT                   /evidence="ECO:0007829|PDB:5VL3"
FT   STRAND          254..256
FT                   /evidence="ECO:0007829|PDB:5VKM"
FT   STRAND          261..272
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          276..281
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          284..286
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          291..296
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   HELIX           301..303
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          305..312
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          317..319
FT                   /evidence="ECO:0007829|PDB:5VKJ"
FT   STRAND          323..327
FT                   /evidence="ECO:0007829|PDB:5VKJ"
SQ   SEQUENCE   847 AA;  95348 MW;  38EB0BE4220ACA2D CRC64;
     MHLLGPWLLL LVLEYLAFSD SSKWVFEHPE TLYAWEGACV WIPCTYRALD GDLESFILFH
     NPEYNKNTSK FDGTRLYEST KDGKVPSEQK RVQFLGDKNK NCTLSIHPVH LNDSGQLGLR
     MESKTEKWME RIHLNVSERP FPPHIQLPPE IQESQEVTLT CLLNFSCYGY PIQLQWLLEG
     VPMRQAAVTS TSLTIKSVFT RSELKFSPQW SHHGKIVTCQ LQDADGKFLS NDTVQLNVKH
     TPKLEIKVTP SDAIVREGDS VTMTCEVSSS NPEYTTVSWL KDGTSLKKQN TFTLNLREVT
     KDQSGKYCCQ VSNDVGPGRS EEVFLQVQYA PEPSTVQILH SPAVEGSQVE FLCMSLANPL
     PTNYTWYHNG KEMQGRTEEK VHIPKILPWH AGTYSCVAEN ILGTGQRGPG AELDVQYPPK
     KVTTVIQNPM PIREGDTVTL SCNYNSSNPS VTRYEWKPHG AWEEPSLGVL KIQNVGWDNT
     TIACAACNSW CSWASPVALN VQYAPRDVRV RKIKPLSEIH SGNSVSLQCD FSSSHPKEVQ
     FFWEKNGRLL GKESQLNFDS ISPEDAGSYS CWVNNSIGQT ASKAWTLEVL YAPRRLRVSM
     SPGDQVMEGK SATLTCESDA NPPVSHYTWF DWNNQSLPYH SQKLRLEPVK VQHSGAYWCQ
     GTNSVGKGRS PLSTLTVYYS PETIGRRVAV GLGSCLAILI LAICGLKLQR RWKRTQSQQG
     LQENSSGQSF FVRNKKVRRA PLSEGPHSLG CYNPMMEDGI SYTTLRFPEM NIPRTGDAES
     SEMQRPPPDC DDTVTYSALH KRQVGDYENV IPDFPEDEGI HYSELIQFGV GERPQAQENV
     DYVILKH
//
